199 results on '"S. Luzzago"'
Search Results
2. MRI-Targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: Follow-up of a precision trial-like retrospective cohort
3. Comparison between small renal masses 0–2cm vs. 2.1–4 cm in size: a population-based study
4. Prognostic role of preoperative neutrophil-to-lymphocyte ratio in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy
5. Robot-assisted radical cystectomy for bladder cancer: a comparison between intracorporeal vs. extracorporeal orthotopic neobladder
6. The effect of age on cancer-specific mortality in patients with prostate cancer: A population-based study across all stages
7. Oligometastatic prostate cancer: Multidisciplinary treatment vs. standard of care
8. MRI-targeted or standard biopsy for prostate cancer diagnosis in biopsy naïve patients. The PRECISION trial follow-up
9. Distribution of histological subtypes and tumor grade according to tumor size in T1-T2 surgically treated renal cell carcinoma
10. Robot-assisted intracorporeal orthotopic ileal neobladder: Description of the 'Shell' technique
11. PO-1772 Radiomic feature relevance in the prediction of pathological features of prostate cancer
12. New size cut-off proposed by EAU Renal Cancer Working group better identifies patients who can benefit from local tumor ablation
13. Added value of MRI radiomics to predict pathological status of prostate cancer patients
14. The impact of histology and type of energy used on oncological outcomes after local tumor ablation of small renal masses
15. Cancer-specific mortality free survival rates in non-metastatic non-clear cell renal carcinoma patients at intermediate/high risk of recurrence
16. Predicting the risk of biochemical recurrence at five years in patients treated with radical prostatectomy for prostate cancer: The PIPEN categories
17. Radio-guided surgery with DROP-IN beta probe for 68Ga-PSMA, in high-risk prostate cancer patients eligible for robotic-assisted radical prostatectomy
18. Three-dimensional prostate model use and augmented reality guided frozen section analysis during robot-assisted radical prostatectomy
19. Evaluating the impact of complications on survival outcomes in patients treated with radical cystectomy for bladder cancer. Results from an european multi-institutional collaboration (YAU urothelial cancer group)
20. Effect of body mass index and obesity on perioperative and oncological outcomes in patients treated with thermal ablation for T1 renal cell tumors
21. Thermal ablation for small renal masses: identifying anthropometric predictors of surgical and oncologic outcomes
22. Three-dimensional prostate model use and augmented-reality guided frozen section analysis during robot-assisted radical prostatectomy
23. MO-0385 Added value of MRI radiomics to predict pathological status of prostate cancer patients
24. PO-1482 Estimation of inter-fraction motion of pelvic organs in SBRT treatments of prostate oligometastases
25. PO-1360 Nutritional and inflammatory status as predictive biomarkers in oligorecurrent PCa (RADIOSA TRIAL)
26. PD-0412 Impact of adjuvant radiotherapy on biochemical recurrence rates for pn1 prostate cancer patients
27. Differences in oncological outcomes and complication rates in patients treated with either radiofrequency or microwaves thermal ablation for T1 renal cell tumours
28. Perioperative and oncological outcomes in patients with a solitary kidney treated with thermal ablation for T1 renal cell tumour
29. Association between histology and oncological outcomes or complication rates in patients treated with thermal ablation for T1 renal cell tumours
30. Differences in oncological outcomes in patients treated with thermal ablation for T1 renal cell masses: complete ablation vs. partial ablation +/- immediate re-treatment
31. The effect of age on cancer-specific mortality in T1a stage renal cell carcinoma patients: a population-based study across all treatment’s modalities
32. Thermal ablation for small renal masses: identifying the most appropriate tumor size cut-off for predicting perioperative and oncological outcomes
33. Organ preserving surgery after glansectomy of partial penectomy in patients with recurrent penile cancer: oncological results
34. Perc-score as a nephrometry scoring system in percutaneous tumour ablation: comparison with renal, mrenal, padua and spare in a multi-centre series
35. Comparison of automated segmentation techniques for magnetic resonance images of the prostate
36. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
37. Validation of the recommended size cut-off for thermal ablation in T1 renal cell carcinoma patients, according to the EAU Guidelines
38. Conditional survival of patients with low-risk prostate cancer: Temporal changes in active surveillance permanence according to risk stratification
39. Impact of postoperative radiotherapy on biochemical recurrence in pn1 prostate cancer patients: establishing the most appropriate timing for radiotherapy administration
40. Multiparametric magnetic resonance of the prostate during active surveillance for low-risk prostate cancer: Time to reduce the number of follow-up biopsies?
41. Multiparametric MRI represents an added value but not a substitute of follow-up biopsies in patients on active surveillance for low-risk prostate cancer
42. Pathological findings at radical prostatectomy after initial active surveillance in low-risk prostate cancer patients. Did we miss the chance to cure?
43. First repeated biopsy represents the most informative predictor of progression-free survival at 3 years follow-up in patients included in an active surveillance protocol for low-risk prostate cancer
44. Impact of stage migration on bladder cancer: A slow but steady improvement in the long term survival rates after radical cystectomy in the last 25 years
45. 446 Salvage lymph node dissection for clinically recurrent prostate cancer: Which patients do benefit from this approach?
46. 456 Patterns of clinical recurrence and impact of site of metastasis on mortality of patients with node positive prostate cancer after radical prostatectomy and extended pelvic lymph node dissection
47. Microwave vs radiofrequency ablation for small renal masses: perioperative and oncological outcomes.
48. Differences in life expectancy of adrenocortical carcinoma patients vs. age‑ and sex-matched population controls.
49. Impact of smoking exposure on disease progression in high risk and very high-risk nonmuscle invasive bladder cancer patients undergoing BCG therapy.
50. Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guérin response among bladder cancer patients: a novel machine-learning approach.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.